Orchid Ventures, a California-based, multi-state cannabis brand, has entered into an agreement to purchase assets from GreenBloom Cannabis Co., a vertically integrated cannabis operator with five retail stores, two cultivation facilities, one distribution entity and six brands across Oregon and California. Per the agreement, Orchid will acquire five of... Read more
Orchid Ventures, a California-based, multi-state cannabis brand, has entered into an agreement to purchase assets from GreenBloom Cannabis Co., a vertically integrated cannabis operator with five retail stores, two cultivation facilities, one distribution entity and six brands across Oregon and California. Per the agreement, Orchid will acquire five of... Read more
Orchid Ventures, a California-based, multi-state cannabis brand, has entered into an agreement to purchase assets from GreenBloom Cannabis Co., a vertically integrated cannabis operator with five retail stores, two cultivation facilities, one distribution entity and six brands across Oregon and California. Per the agreement, Orchid will acquire five of... Read more
Laval, Québec, CANADA – July 18, 2019 – PRESS RELEASE – Neptune Wellness Solutions Inc., a North American cannabinoids extraction, formulation and packaging company, has completed a private placement with both existing and new institutional investors, led by Perceptive Advisors, resulting in gross proceeds to the company of US$41.4 million.... Read more
Laval, Québec, CANADA – July 18, 2019 – PRESS RELEASE – Neptune Wellness Solutions Inc., a North American cannabinoids extraction, formulation and packaging company, has completed a private placement with both existing and new institutional investors, led by Perceptive Advisors, resulting in gross proceeds to the company of US$41.4 million.... Read more
The Food and Drug Administration has begun developing regulatory guidance on CBD, and commissioners have invited the public to weigh in on how to proceed. A public comment period closed this week, providing the FDA with nearly 3,500 perspectives on the legality, availability and apparent health benefits of CBD... Read more
The Food and Drug Administration has begun developing regulatory guidance on CBD, and commissioners have invited the public to weigh in on how to proceed. A public comment period closed this week, providing the FDA with nearly 3,500 perspectives on the legality, availability and apparent health benefits of CBD... Read more
The Food and Drug Administration has begun developing regulatory guidance on CBD, and commissioners have invited the public to weigh in on how to proceed. A public comment period closed this week, providing the FDA with nearly 3,500 perspectives on the legality, availability and apparent health benefits of CBD... Read more
TEL AVIV, Israel, July 16, 2019 – PRESS RELEASE – Kanabo Research Ltd., an Israeli R&D canna-tech company, has announced that it has signed a cooperative agreement with Kibbutz Gezer to establish a joint cultivation facility for medicinal cannabis. Kanabo, which develops, medically validates and commercializes vape-based medicinal cannabis... Read more
TEL AVIV, Israel, July 16, 2019 – PRESS RELEASE – Kanabo Research Ltd., an Israeli R&D canna-tech company, has announced that it has signed a cooperative agreement with Kibbutz Gezer to establish a joint cultivation facility for medicinal cannabis. Kanabo, which develops, medically validates and commercializes vape-based medicinal cannabis... Read more